EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Lipid Metabolism and Cardiovascular Risk in HIV-1 Infection and HAART: Present and Future Problems

Sara Melzi, Laura Carenzi, Maria Vittoria Cossu, Simone Passerini, Amedeo Capetti, Giuliano Rizzardini

Cholesterol · 2010

DOI: 10.1155/2010/271504 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cholesterol, 2010. Verfasst von Sara Melzi und 5 weiteren Autor:innen. Beteiligte Einrichtung: 1st Division of Infectious Diseases, "Luigi Sacco" Hospital, Via GB Grassi, 74, 20157 Milan, Italy. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Many infections favor or are directly implicated with lipid metabolism perturbations and/or increased risk of coronary heart disease (CHD). HIV itself has been shown to increase lipogenesis in the liver and to alter the lipid profile, while the presence of unsafe habits, addiction, comorbidities, and AIDS-related diseases increases substantially the risk of cardiovascular disease (CVD) in the HIV-infected population. Antiretroviral therapy reduces such stimuli but many drugs have intrinsic toxicity profiles impacting on metabolism or potential direct cardiotoxicity. In a moment when the main guidelines of HIV therapy are predating the point when to start treating, we mean to highlight the contribution of HIV-1 to lipid alteration and inflammation, the impact of antiretroviral therapy, the decisions on what drugs to use to reduce the probability of having a cardiovascular event, the increasing use of statins and fibrates in HIV-1 infected subjects, and finally the switch strategies, that balance effectiveness and toxicity to move the decision to change HIV drugs. Early treatment might reduce the negative effect of HIV on overall cardiovascular risk but may also evidence the impact of drugs, and the final balance (reduction or increase in CHD and lipid abnormalities) is not known up to date.

Autor:innen und Institutionen

  • 1st Division of Infectious Diseases, "Luigi Sacco" Hospital, Via GB Grassi, 74, 20157 Milan, Italy.

Zitieren

APA

Melzi, S., Carenzi, L., Cossu, M. V., Passerini, S., Capetti, A., & Rizzardini, G. (2010). Lipid Metabolism and Cardiovascular Risk in HIV-1 Infection and HAART: Present and Future Problems. Cholesterol. https://doi.org/10.1155/2010/271504

Vancouver

Melzi S, Carenzi L, Cossu MV, Passerini S, Capetti A, Rizzardini G. Lipid Metabolism and Cardiovascular Risk in HIV-1 Infection and HAART: Present and Future Problems. Cholesterol. 2010. doi:10.1155/2010/271504

BibTeX
@article{Melzi2010,
  author = {Melzi, Sara and Carenzi, Laura and Cossu, Maria Vittoria and Passerini, Simone and Capetti, Amedeo and Rizzardini, Giuliano},
  title = {Lipid Metabolism and Cardiovascular Risk in HIV-1 Infection and HAART: Present and Future Problems},
  journal = {Cholesterol},
  year = {2010},
  doi = {10.1155/2010/271504}
}
Kostenlos starten →